Market Research Logo

Newborn Screening Market Analysis By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assay And Electrophoresis), By Type of Test (Dry Blood Spot Test, CCHD And Hearing Screen), By Product (Instruments And Reagents) And Segmen

Newborn Screening Market Analysis By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assay, DNA Assay And Electrophoresis), By Type of Test (Dry Blood Spot Test, CCHD And Hearing Screen), By Product (Instruments And Reagents) And Segment Forecasts To 2022

The global newborn screening market is expected to reach USD 1.43 billion by 2022, according to a new report by Grand View Research Inc. Increasing occurrence of congenital disorders that lead to mental retardation or dysfunctioning body organs and the availability of advanced screening technologies are expected to drive market growth over the forecast period.

Furthermore, the market is expected to witness a boost in demand owing to, the presence of Federal Bodies involved in organizing awareness and quality assurance programs to imbibe faith and decrease the number of deaths caused due to negligence & non-screening. For instance, in 2011, the Ministry of Health, Japan recommended the use of mass spectrometry in newborn screening and by 2014, the entire nation started utilizing it for 19 critical conditions.

Further key findings from the report suggest:

Tandem mass spectroscopy is expected to account for over 25% of newborn screening market share by 2022, owing to its ability to render faster diagnosis and cost effectiveness.

Pulse oximetry is expected to witness gains of over 9.0% over the forecast period. Masimo’s Eve software and Radical-7 oximeter gained CE marking in 2014 leading to a growth in demand supported by quality assurance and better analysis.

Dry blood spot test is expected to witness lucrative growth over the forecast period. Free distribution of filter paper by government is expected to boost the primary screening of all newborns, thereby, accelerating market growth.

Presently, 100% screening of over 4 million neonates is carried out in the North America annually. Encouraging efforts to prevent long term disabilities by healthcare providers and government agencies are some vital factors influencing regional market growth. Presence of favorable reimbursement policies reduces the burden of treatment cost, thereby, promoting higher procedure volumes

Asia Pacific newborn screening market is expected to witness the fastest growth of over 11.0% during the forecast period. This growth is attributed to the presence of large untapped opportunities, rising healthcare expenditure levels, increasing disease prevalence rate, and the introduction of supportive government initiatives.

Some key players of this market include Agilent Technologies Inc., AB Sciex LLC, Natus Medical Inc., PerkinElmer Inc., Covidien Plc, Masimo Corp., Trivitron Healthcare, Bio-Rad Laboratories Inc. GE Healthcare and Waters Corp.

Market participants are constantly engaged in developing technologically advanced products in an attempt to improve presence and ensure sustainability. PerkinElmer’s “EnLite Neonatal TREC Kit” gained FDA approval in 2014 for the diagnosis and treatment of Severe Combined Immunodeficiency Disease (SCID) leading to replacement of non-approved tests in certain states of the U.S.

Over 20 states along with the Navajo Nation and the District of Columbia have put screening programs into practice for the same.

Grand View Research has segmented the global newborn screening market on the basis of product, technology, test type and region:

Product Outlook (Revenue, USD Million, 2012 - 2022)

Instruments

Reagents & Assay Kits

Technology Outlook (Revenue, USD Million, 2012 - 2022)

Tandem Mass Spectrometry

Pulse Oximetry

Enzyme Based Assays

DNA Assays

Electrophoresis

Test Outlook (Revenue, USD Million, 2012 - 2022)

Dry Blood Spot Test

Critical Congenital Heart Disease (CCHD)

Hearing Screen

Regional Outlook (Revenue, USD Million, 2012 - 2022)

North America

U.S.

Canada

Europe

UK

Germany

France

Rest of Europe

Asia Pacific

Japan

China

India

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa (MEA)

South Africa

Rest of Middle East and Africa


Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Newborn screening- Industry Summary and Key Buying Criteria, 2012 - 2022
Chapter 3. Newborn Screening Industry Outlook
3.1. Newborn screening market segmentation
3.2. Newborn screening market size and growth prospects, 2012 - 2022
3.3. Newborn screening market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Key opportunities prioritized
3.5. Industry analysis - Porter's
3.6. Newborn screening company market share, 2014
3.7. Newborn screening market PESTEL analysis, 2014
Chapter 4. Newborn Screening Technology Outlook
4.1. Newborn Screening market share by technology, 2014 & 2022
4.2. Tandem mass spectrometry market estimates and forecasts, 2012 - 2022 (USD Million)
4.3. Pulse oximetry market estimates and forecasts, 2012 - 2022 (USD Million)
4.4. Enzyme based assays market estimates and forecasts, 2012 - 2022 (USD Million)
4.5. DNA assays market estimates and forecasts, 2012 - 2022 (USD Million)
4.6. Electrophoresis market estimates and forecasts, 2012 - 2022 (USD Million)
Chapter 5. Newborn Screening Test Type Outlook
5.1. Newborn Screening market share by test type, 2014 & 2022
5.2. Dry blood spot test market estimates and forecasts, 2012 - 2022 (USD Million)
5.3. Critical congenital heart disease (CCHD) market estimates and forecasts, 2012 - 2022 (USD Million)
5.4. Hearing screen test market estimates and forecasts, 2012 - 2022 (USD Million)
Chapter 6. Newborn Screening Product Outlook
6.1. Newborn Screening market share by product, 2014 & 2022
6.2. Instruments market estimates and forecasts, 2012 - 2022 (USD Million)
6.3. Reagents and assay kits market estimates and forecasts, 2012 - 2022 (USD Million)
Chapter 7. Newborn Screening Regional Outlook
7.1. North America
7.1.1. North America market, by technology, 2012 - 2022 (USD Million)
7.1.1.1. U.S. market estimates and forecasts
7.1.1.2. Canada market estimates and forecasts
7.1.2. North America market, by test type, 2012 - 2022 (USD Million)
7.1.2.1. U.S. market estimates and forecasts
7.1.2.2. Canada market estimates and forecasts
7.1.3. North America market, by product, 2012 - 2022 (USD Million)
7.1.3.1. U.S. market estimates and forecasts
7.1.3.2. Canada market estimates and forecasts
7.2. Europe
7.2.1. Europe market, by technology, 2012 - 2022 (USD Million)
7.2.1.1. UK market estimates and forecasts
7.2.1.2. Germany market estimates and forecasts
7.2.1.3. France market estimates and forecasts
7.2.2. Europe market, by test type, 2012 - 2022 (USD Million)
7.2.2.1. UK market estimates and forecasts
7.2.2.2. Germany market estimates and forecasts
7.2.2.3. France market estimates and forecasts
7.2.3. Europe market, by product, 2012 - 2022 (USD Million)
7.2.3.1. UK market estimates and forecasts
7.2.3.2. Germany market estimates and forecasts
7.2.3.3. France market estimates and forecasts
7.3. Asia Pacific
7.3.1. Asia Pacific market, by technology, 2012 - 2022 (USD Million)
7.3.1.1. India market estimates and forecasts
7.3.1.2. China market estimates and forecasts
7.3.1.3. Japan market estimates and forecasts
7.3.2. Asia Pacific market, by test type, 2012 - 2022 (USD Million)
7.3.2.1. India market estimates and forecasts
7.3.2.2. China market estimates and forecasts
7.3.2.3. Japan market estimates and forecasts
7.3.3. Asia Pacific market, by product, 2012 - 2022 (USD Million)
7.3.3.1. India market estimates and forecasts
7.3.3.2. China market estimates and forecasts
7.3.3.3. Japan market estimates and forecasts
7.4. Latin America
7.4.1. Latin America market, by technology, 2012 - 2022 (USD Million)
7.4.1.1. Mexico market estimates and forecasts
7.4.1.2. Brazil market estimates and forecasts
7.4.2. Latin America market, by test type, 2012 - 2022 (USD Million)
7.4.2.1. Mexico market estimates and forecasts
7.4.2.2. Brazil market estimates and forecasts
7.4.3. Latin America market, by product, 2012 - 2022 (USD Million)
7.4.3.1. Mexico market estimates and forecasts
7.4.3.2. Brazil market estimates and forecasts
7.5. MEA
7.5.1. MEA market, by technology, 2012 - 2022 (USD Million)
7.5.1.1. South Africa market estimates and forecasts
7.5.2. MEA market, by test type, 2012 - 2022 (USD Million)
7.5.2.1. South Africa market estimates and forecasts
7.5.3. MEA market, by product, 2012 - 2022 (USD Million)
7.5.3.1. South Africa market estimates and forecasts
Chapter 8. Competitive Landscape
8.1. Covidien Plc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. AB SCIEX
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Bio Rad Laboratories
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Agilent Technologies
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Masimo Corporation
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Waters Corporation
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Natus Medical
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Trivitron Healthcare
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. GE Lifesciences
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. PerkinElmer Inc
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
List of Tables
1. Newborn Screening - Industry Snapshot
2. Newborn Screening Market, by Product, 2012 - 2022 (USD million)
3. Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
4. Newborn Screening Market, by Test, 2012 - 2022 (USD million)
5. Newborn Screening Market, by Region, 2012 - 2022 (USD million)
6. Newborn Screening Market - Key Market Drivers Analysis
7. Newborn Screening Market - Key Market Restraints Analysis
8. North America Newborn Screening Market, by Product, 2012 - 2022 (USD million)
9. North America Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
10. North America Newborn Screening Market, by Test, 2012 - 2022 (USD million)
11. U.S. Newborn Screening Market, by Product, 2012 - 2022 (USD million)
12. U.S. Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
13. U.S. Newborn Screening Market, by Test, 2012 - 2022 (USD million)
14. Canada Newborn Screening Market, by Product, 2012 - 2022 (USD million)
15. Canada Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
16. Canada Newborn Screening Market, by Test, 2012 - 2022 (USD million)
17. Europe Newborn Screening Market, by Product, 2012 - 2022 (USD million)
18. Europe Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
19. Europe Newborn Screening Market, by Test, 2012 - 2022 (USD million)
20. UK Newborn Screening Market, by Product, 2012 - 2022 (USD million)
21. UK Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
22. UK Newborn Screening Market, by Test, 2012 - 2022 (USD million)
23. Germany Newborn Screening Market, by Product, 2012 - 2022 (USD million)
24. Germany Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
25. Germany Newborn Screening Market, by Test, 2012 - 2022 (USD million)
26. France Newborn Screening Market, by Product, 2012 - 2022 (USD million)
27. France Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
28. France Newborn Screening Market, by Test, 2012 - 2022 (USD million)
29. Asia Pacific Newborn Screening Market, by Product, 2012 - 2022 (USD million)
30. Asia Pacific Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
31. Asia Pacific Newborn Screening Market, by Test, 2012 - 2022 (USD million)
32. Japan Newborn Screening Market, by Product, 2012 - 2022 (USD million)
33. Japan Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
34. Japan Newborn Screening Market, by Test, 2012 - 2022 (USD million)
35. China Newborn Screening Market, by Product, 2012 - 2022 (USD million)
36. China Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
37. China Newborn Screening Market, by Test, 2012 - 2022 (USD million)
38. India Newborn Screening Market, by Product, 2012 - 2022 (USD million)
39. India Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
40. India Newborn Screening Market, by Test, 2012 - 2022 (USD million)
41. Latin America Newborn Screening Market, by Product, 2012 - 2022 (USD million)
42. Latin America Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
43. Latin America Newborn Screening Market, by Test, 2012 - 2022 (USD million)
44. Brazil Newborn Screening Market, by Product, 2012 - 2022 (USD million)
45. Brazil Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
46. Brazil Newborn Screening Market, by Test, 2012 - 2022 (USD million)
47. Mexico Newborn Screening Market, by Product, 2012 - 2022 (USD million)
48. Mexico Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
49. Mexico Newborn Screening Market, by Test, 2012 - 2022 (USD million)
50. Middle East and Africa (MEA) Market, by Product, 2012 - 2022 (USD million)
51. Middle East and Africa (MEA) Market, by Technology, 2012 - 2022 (USD million)
52. Middle East and Africa (MEA) Market, by Test, 2012 - 2022 (USD million)
53. South Africa Newborn Screening Market, by Product, 2012 - 2022 (USD million)
54. South Africa Newborn Screening Market, by Technology, 2012 - 2022 (USD million)
55. South Africa Newborn Screening Market, by Test, 2012 - 2022 (USD million)
List of Figures
1. Newborn Screening Market Segmentation
2. Global Newborn Screening Market Revenue, 2012 - 2022
3. Newborn Screening Market Dynamics
4. Key Opportunities Prioritized
5. Newborn Screening Market Analysis - Porter's
6. Newborn Screening Process Illustration
7. Newborn Screening Market Analysis - PESTEL Analysis
8. Global Newborn Screening Market , By Product, 2012 - 2022 (USD million)
9. Instruments Market, 2012 - 2022 (USD million)
10. Reagents Market, 2012 - 2022 (USD million)
11. Global Newborn Screening Market, By Technology, 2012 to 2022 (USD million)
12. Tandem Mass Spectrometry Market, 2012 to 2022 (USD million)
13. Pulse Oximetry Market, 2012 to 2022 (USD million)
14. Enzyme Based Assays Market, 2012 to 2022 (USD million)
15. DNA Assays Market, 2012 to 2022 (USD million)
16. Electrophoresis Market, 2012 to 2022 (USD million)
17. Global Newborn Screening Market, By Test, 2012 to 2022 (USD million)
18. Dry Blood Spot Test Market, 2012 to 2022 (USD million)
19. Critical Congenital Heart Disease (CCHD) Market, 2012 to 2022 (USD million)
20. Hearing Screen Market, 2012 to 2022 (USD million)
21. Global Newborn Screening Market, By Region 2012 to 2022 (USD million)
22. North America Market, by Product, 2012 to 2022 (USD million)
23. North America Market, by Technology, 2012 to 2022 (USD million)
24. North America Market, by Test, 2012 to 2022 (USD million)
25. U.S. Market, by Product, 2012 to 2022 (USD million)
26. U.S. Market, by Technology, 2012 to 2022 (USD million)
27. U.S. Market, by Test, 2012 to 2022 (USD million)
28. Canada Market, by Product, 2012 to 2022 (USD million)
29. Canada Market, by Technology, 2012 to 2022 (USD million)
30. Canada Market, by Test, 2012 to 2022 (USD million)
31. Europe Market, by Product, 2012 to 2022 (USD million)
32. Europe Market, by Technology, 2012 to 2022 (USD million)
33. Europe Market, by Test, 2012 to 2022 (USD million)
34. UK Market, by Product, 2012 to 2022 (USD million)
35. UK Market, by Technology, 2012 to 2022 (USD million)
36. UK Market, by Test, 2012 to 2022 (USD million)
37. Germany Market, by Product, 2012 to 2022 (USD million)
38. Germany Market, by Technology, 2012 to 2022 (USD million)
39. Germany Market, by Test, 2012 to 2022 (USD million)
40. France Market, by Product, 2012 to 2022 (USD million)
41. France Market, by Technology, 2012 to 2022 (USD million)
42. France Market, by Test, 2012 to 2022 (USD million)
43. Asia Pacific Market, by Product, 2012 to 2022 (USD million)
44. Asia Pacific Market, by Technology, 2012 to 2022 (USD million)
45. Asia Pacific Market, by Test, 2012 to 2022 (USD million)
46. Japan Market, by Product, 2012 to 2022 (USD million)
47. Japan Market, by Technology, 2012 to 2022 (USD million)
48. Japan Market, by Test, 2012 to 2022 (USD million)
49. China Market, by Product, 2012 to 2022 (USD million)
50. China Market, by Technology, 2012 to 2022 (USD million)
51. China Market, by Test, 2012 to 2022 (USD million)
52. India Market, by Product, 2012 to 2022 (USD million)
53. India Market, by Technology, 2012 to 2022 (USD million)
54. India Market, by Test, 2012 to 2022 (USD million)
55. Latin America Market, by Product, 2012 to 2022 (USD million)
56. Latin America Market, by Technology, 2012 to 2022 (USD million)
57. Latin America Market, by Test, 2012 to 2022 (USD million)
58. Brazil Market, by Product, 2012 to 2022 (USD million)
59. Brazil Market, by Technology, 2012 to 2022 (USD million)
60. Brazil Market, by Test, 2012 to 2022 (USD million)
61. Mexico Market, by Product, 2012 to 2022 (USD million)
62. Mexico Market, by Technology, 2012 to 2022 (USD million)
63. Mexico Market, by Test, 2012 to 2022 (USD million)
64. Middle East and Africa (MEA) Market, by Product, 2012 to 2022 (USD million)
65. Middle East and Africa (MEA) Market, by Technology, 2012 to 2022 (USD million)
66. Middle East and Africa (MEA) Market, by Test, 2012 to 2022 (USD million)
67. South Africa Market, by Product, 2012 to 2022 (USD million)
68. South Africa Market, by Technology, 2012 to 2022 (USD million)
69. South Africa Market, by Test, 2012 to 2022 (USD million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report